No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / administration & dosage*
-
Anticoagulants / adverse effects
-
Anticoagulants / pharmacokinetics
-
Dabigatran / administration & dosage*
-
Dabigatran / adverse effects
-
Dabigatran / pharmacokinetics
-
Drug Interactions
-
Humans
-
Outpatients*
-
Pyrazoles / administration & dosage*
-
Pyrazoles / adverse effects
-
Pyrazoles / pharmacokinetics
-
Pyridines / administration & dosage*
-
Pyridines / adverse effects
-
Pyridines / pharmacokinetics
-
Pyridones / administration & dosage*
-
Pyridones / adverse effects
-
Pyridones / pharmacokinetics
-
Renal Insufficiency, Chronic / drug therapy*
-
Rivaroxaban / administration & dosage*
-
Rivaroxaban / adverse effects
-
Rivaroxaban / pharmacokinetics
-
Thiazoles / administration & dosage*
-
Thiazoles / adverse effects
-
Thiazoles / pharmacokinetics
-
Venous Thromboembolism / drug therapy*
Substances
-
Anticoagulants
-
Pyrazoles
-
Pyridines
-
Pyridones
-
Thiazoles
-
apixaban
-
Rivaroxaban
-
Dabigatran
-
edoxaban